From an extract of the stem bark of Xymalos monospora, a bis-benzylisoquinoline alkaloid (1), three benzylisoquinoline alkaloids (mollinedine, 1-(p-methoxybenzyl)-6,7-methylenedioxyisoquino-line, doryafranine), and an aporphine alkaloid (N-methyllaurotetanine) were isolated. These compounds were tested for growth inhibitory activity against bloodstream forms of three strains of African trypanosomes. In vitro IC 50 values starting from 1.8 μg /mL were obtained.
Xymalos monospora Baill. belongs to the botanical family Monimiaceae, which comprises 34 genera and about 440 species [1] . X. monospora is a montane tree which is used medicinally for gastro-intestinal complaints [2] . Our interest has recently been focused on plants used for the treatment of parasitic diseases caused by protozoa, which included malaria [3] and African trypanosomiasis or sleeping sickness [4] . A resurgence of this later disease is devastating for populations in Southern Sudan, the Congo, and other sub-Saharan African countries [5] . Since current antitrypanosomal drugs suffer from their limited efficacies, human toxicity, and high cost, plus the emergence of drug-resistant trypanosome strains [6] , there is a great need for new trypanosomal agents that are safer, and natural products may appear to be useful in that respect; X. monospora was identified as a potential anti-parasitic plant species. The alkaloid fraction from its stem bark extract was then tested for growth inhibitory activity, in vitro, against bloodstream forms of African trypanosomes. The IC 50 values obtained were 8.6 μg/mL for Lab 110 EATRO, a drug sensitive strain of Trypanosoma brucei brucei, 5.0 μg/mL for KETRI 243, an uncloned clinically isolated strain of T. brucei rhodesiense, and 8.6 μg/mL for KETRI 243 As 10-3, a pentamidine and melarsol-resistant strain of T. brucei rhodesiense KETRI 243. Column chromatography of the extract then led to the isolation of 5 alkaloids, which were subsequently tested, and the results are summarized in Table 1 .
Air-dried stem bark of X. monospora was extracted with methanol and, after recovery of the solvent, the extract was dissolved in a mixture containing 250 mL MeOH, 50 mL H 2 O, and 400 mL 15% acetic acid. The acetic acid solution was defatted with n-hexane, alkalinized and successively extracted with methylene chloride. The resulting CH 2 Cl 2 -soluble fractions were concentrated and purified by chromatographic techniques to furnish a bis-benzylisoquinoline (1) alkaloid, three benzyl-NPC Natural Product Communications isoquinolines (mollinedine, 1-(p-methoxybenzyl)-6,7-methylenedioxyisoquinoline, doryafranine), and an aporphine alkaloid (N-methyllaurotetanine).
Compound (1) was obtained as a dark gum. The elemental composition C 37 H 42 N 2 O 6 was obtained by combined analysis of its EIMS (m/z 610) and NMR spectroscopic data. Predominant ion peaks observed in the MS at m/z 192 and 206 were typical of bis-benzylisoquinolines [7, 8] . The 1 H NMR spectrum displayed signals for three methoxy groups at δ 3.57 and 3.81 (6H), and two N-methyls at δ 2.50 and 2.45, as well as eleven aromatic protons between δ 6.02-7.00. The 13 C NMR data displayed signals for 35 non-exchangeable carbon atoms. Analysis of these data, as well as those from 2D experiments (HMQC, HMBC, COSY, and NOESY) led to the characterization of 1 as epi-temuconine. The data of 1 were very similar to those reported for (+)-temuconine obtained from Berberis valdiviana [7] . The major difference was in their optical rotations: [α] D = +68.0° (+)-temuconine and [α] D = -124.6° for epi-temuconine (1) . The CD spectrum of epi-temuconine (1) exhibited troughs at 286 and 234 nm, pointing to a 1S, 1'R configuration [7] . A similar compound, (-)-temuconine, was isolated from Aristolachia elegans [9] and was said to be the enantiomeric form of (+)-temuconine, but it has a methoxy group at C-7' instead of at C-7, as in epi-temuconine (1) . Other compounds were identified as mollinedine [10] , 1-(p-methoxybenzyl)-6,7-methylenedioxyisoquinoline [11] , doryafranine [12] and Nmethyllaurotetanine [13] , respectively on the basis of their spectroscopic analysis.
The isolation of alkaloids from X. monospora is in accordance with the general description of the Monimiaceae family, which is known as a rich source of benzylisoquinoline and aphorphine-type alkaloids. Furthermore, except for epi-temuconine (1) and 1-(pmethoxybenzyl)-6,7-methylenedioxyisoquinoline, the other alkaloids obtained in the present study have previously been reported as constituents of that family.
Four of the isolated alkaloids were assayed for trypanocidal activity against bloodstream forms of T. brucei brucei and T. brucei rhodesiense isolates grown in vitro in 24 well plates. Coulter counts were made daily and the IC 50 values determined after 48 h are given in Table 1 . Mollinedine and 1-(p-methoxybenzyl)-6,7-methylenedioxyisoquinoline have comparable IC 50 values for the two KETRI strains of T. brucei rhodesiense (human pathogen) used in our assays. However, 1-(p-methoxybenzyl)-6,7-methylenedioxyisoquino-line (IC 50 = 2.3 μg/mL) is about 10 times more active than mollinedine (IC 50 = 21.5 μg/mL) for the Lab 110 strain of T. brucei brucei, a veterinary pathogen. epi-Temuconine (1) appeared to be the most effective of the five isolated alkaloids of X. monospora, with inhibitor concentrations in the range of 2-5 μg /mL for all isolates tested. It should be noted that 1 was the major component (ca 5% of the alkaloid fraction). The amount of doryafranine did not allow us to obtain its trypanocidal data. Corresponding IC 50 values for the trypanocides melarsoprol and pentamidine were ~ 300 -5000 fold lower. spectrophotometer. 1 H NMR (500 MHz) and 13 C NMR (125 MHz) spectra were recorded in CDCl 3 using a Bruker ARX500 spectrometer with an inverse multinuclear 5 mm probe head equipped with a shielded gradient coil. The chemical shifts (δ) are reported in parts per million relative to chloroform (7.26 ppm for CHCl 3 and 77.0 ppm for CDCl 3 ) while the coupling constants (J) are given in Hertz. COSY, HMQC and HMBC experiments were recorded with gradient enhancements using sine shaped gradient pulses. For 2D heteronuclear correlation spectroscopy the refocusing delays were optimized for 1 J CH = 145 Hz and n J CH = 10 Hz. The raw data were transformed and the spectra evaluated with the standard Bruker UXNMR. EIMS spectra (direct inlet at 70 eV) were recorded with a JEOL SX102 spectrometer. Column chromatography was run on Merck silica gel 60 and neutral alumina (activity III). TLC analyses were carried out on silica gel GF 254 precoated plates with detection accomplished by spraying with a solution of Dragendorff's reagent.
Plant material:
The stem bark of X. monospora was collected from the Northwest Province of Cameroon in December 2000 and identified at the National Herbarium in Yaoundé. A voucher specimen (BUD 0287) was deposited at the Botany Herbarium of the University of Dschang, Cameroon.
Extraction and purification:
The air-dried and pulverized stem bark of X. monospora (6 Kg) was macerated at room temperature (25 o C) in methanol (100 L) for 48 hours, three times. The combined methanol extracts were concentrated to dryness to give 500 g of extract. The presence of alkaloids was revealed by the positive Dragendorff test. The crude methanol extract (500 g) was then dissolved in a mixture containing 250 mL MeOH, 50 mL H 2 O, and 400 mL of 15% acetic acid to form a precipitate (95 g). The mother liquor was washed with n-hexane (2 x 400 mL) to give 20 g of neutral fraction. To the aqueous phase 400 mL CH 2 Cl 2 and 200 mL ammonia were added and the mixture left for 30 min before extraction, which was repeated two more times with 400 mL of CH 2 Cl 2 each time. The alkaloid extract obtained after evaporation of the combined CH 2 Cl 2soluble fractions (45 g) was fractionated on an alumina column (activity III) using CH 2 Cl 2 and mixtures of CH 2 Cl 2 /MeOH 98: 2 and 95:5 to afford fractions A, B, and C, respectively. Fraction A (eluted with pure CH 2 Cl 2 , 2 g) was further purified by successive column chromatography over silica gel with n-hexane/acetone 9:1 and 8:2 as eluents to yield mollinedine (60 mg), 1-(p-methoxybenzyl)-6,7methylenedioxyisoquinoline (30 mg), and doryafranine (8 mg). Fraction B (eluted with CH 2 Cl 2 /MeOH 98:2, 1 g), purified in the same way as fraction A, using n-hexane/acetone 7:3 gave N-methyllaurotetanine (25 mg) and 1 (300 mg). Finally, Fraction C (eluted with CH 2 Cl 2 /MeOH 95:5, 3 g) afforded a supplementary amount of 1 (1.6 g) and a mixture of non-resolved compounds after silica gel column chromatography with n-hexane/acetone 7:3. Antitrypanosomal assay: Assays for inhibition of trypanosomal growth were conducted as previously described [14, 15] . Bloodstream forms of trypanosomes were cultured in modified IMDM with 20% horse serum at 37°C in 5% CO 2 . Drug studies were conducted in duplicate in 24 well plates (1 mL/well) with final inhibitor concentrations of 0.1, 1, 10, 25, and 100 μg/mL. Wells were inoculated with 10 5 trypanosomes and one half the volume of each well was changed daily. After 48 h, the parasite number was determined in a Model Z1 Coulter counter (Beckman Coulter. Miami, Florida, USA) and IC 50 values were calculated from semi-log plots. Compounds were dissolved in 100% dimethylsulfoxide and diluted in medium, so that the dimethylsulfoxide concentration never exceeded 0.3%; a non-inhibitory concentration of control cells without compounds grew to 5 x 10 6 /mL. Strains used were: T. brucei brucei Lab 110 EATRO; and Kenya Trypanosomiasis Research Institute (KETRI) clinical isolates T. brucei rhodesiense 243 and 243 As 10-3. The latter is a melarsen oxide and pentamidine resistant clone of KETRI 243 [7, 8] . Usually, a broad concentration curve was produced, followed by a close concentration curve, from which IC 50 values were determined.
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